$1.40
-0.02[-1.41%]
At close: Apr 26
$1.40
0[0.00%]
After Hours: 5:44PM EDT
Marinus Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Marinus Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | MRNS | Q1 | -$0.67 | -$0.63 | — | — | $10.38M | $9.08M | — | — | Get Alert |
03/05/2024 | PM | MRNS | Q4 | -$0.76 | -$0.62 | -$0.74 | -19.35% | $7.16M | $8.01M | $7.19M | -10.24% | Get Alert |
11/07/2023 | AM | MRNS | Q3 | -$0.94 | -$0.66 | -$0.61 | 7.58% | $2.34M | $6.33M | $7.34M | 15.92% | Get Alert |
08/10/2023 | AM | MRNS | Q2 | -$1.06 | -$0.72 | -$0.61 | 15.28% | $1.79M | $5.73M | $6.08M | 6.13% | Get Alert |
05/11/2023 | AM | MRNS | Q1 | -$0.52 | -$0.72 | -$0.67 | 6.94% | $14.19M | $5.88M | $10.38M | 76.53% | Get Alert |
03/07/2023 | PM | MRNS | Q4 | -$0.77 | -$0.70 | -$0.76 | -8.57% | $1.52M | $5.35M | $7.16M | 33.87% | Get Alert |
11/07/2022 | PM | MRNS | Q3 | -$0.53 | $0.47 | -$0.94 | -300.00% | $10.11M | $29.48M | $2.34M | -92.06% | Get Alert |
08/11/2022 | AM | MRNS | Q2 | -$0.65 | -$0.68 | -$1.06 | -55.88% | $1.91M | $2.31M | $1.79M | -22.51% | Get Alert |
05/12/2022 | PM | MRNS | Q1 | -$0.74 | -$0.85 | -$0.52 | 38.82% | $1.81M | $2.28M | $14.19M | 522.19% | Get Alert |
03/21/2022 | AM | MRNS | Q4 | -$0.55 | -$0.76 | -$0.77 | -1.32% | $1.55M | $3.37M | $1.52M | -54.90% | Get Alert |
11/09/2021 | AM | MRNS | Q3 | -$0.51 | -$0.73 | -$0.53 | 27.40% | $171.00K | — | $10.11M | — | Get Alert |
08/10/2021 | AM | MRNS | Q2 | -$0.64 | -$0.69 | -$0.65 | 5.80% | $0.00 | $2.70M | $1.91M | -29.44% | Get Alert |
05/17/2021 | AM | MRNS | Q1 | -$1.28 | -$0.45 | -$0.74 | -64.44% | $0.00 | $2.57M | $1.81M | -29.73% | Get Alert |
03/09/2021 | AM | MRNS | Q4 | -$1.00 | -$0.51 | -$0.55 | -7.84% | $0.00 | $1.04M | $1.55M | 48.65% | Get Alert |
11/09/2020 | PM | MRNS | Q3 | -$1.04 | -$0.60 | -$0.51 | 15.00% | $0.00 | $420.00K | $171.00K | -59.29% | Get Alert |
08/06/2020 | AM | MRNS | Q2 | -$0.96 | -$0.76 | -$0.64 | 15.79% | $0.00 | — | $0.00 | — | Get Alert |
05/04/2020 | AM | MRNS | Q1 | -$0.96 | -$0.64 | -$1.28 | -100.00% | $0.00 | — | $0.00 | — | Get Alert |
03/16/2020 | AM | MRNS | Q4 | -$0.96 | -$0.84 | -$1.00 | -19.05% | $0.00 | — | $0.00 | — | Get Alert |
11/06/2019 | AM | MRNS | Q3 | -$1.08 | -$0.96 | -$1.04 | -8.33% | $0.00 | — | $0.00 | — | Get Alert |
Marinus Pharma (MRNS) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 5, 2024 for Q4.
The Actual EPS was $-0.74, which missed the estimate of $-0.62.
The Actual Revenue was $7.2M, which missed the estimate of $8M.
Browse earnings estimates, EPS, and revenue on all stocks.